MetaCap

Helus Pharma Inc. Company Profile

NASDAQ: HELPHealth CareBiotechnology: Pharmaceutical PreparationsUSD

6.11-0.67 (-9.88%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Helus Pharma at a glance

Helus Pharma Inc. (NASDAQ: HELP) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Toronto, ON, Canada. Helus Pharma is led by Mr. Michael I. Halstead J.D. and employs about 100 people. At a market capitalization of $487.7 million, it is considered a small-cap company.

Its SEC Central Index Key (CIK) is 0001833141, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Helus Pharma do?

Helus Pharma Inc. operates as a clinical stage pharmaceutical company that focuses on developing therapies to treat psychiatric and neurological conditions. It develops HLP003, a deuterated psilocybin analog, which is in phase 3 clinical trial to treat major depressive disorder; and HLP004, a deuterated N, N-dimethyltryptamine, which is in phase 2 clinical trial for treating generalized anxiety disorders. The company's preclinical product includes HLP005, a phenethylamine and tryptamine derivative to treat central nervous system. It has a strategic partnership agreement with Segal Trials to evaluate HLP003 for the adjunctive treatment of major depressive disorder; and Osmind for mental health treatments. It operates in Canada, the United States, the United Kingdom, and Ireland. The company was formerly known as Cybin Inc. and changed its name to Helus Pharma Inc. in October 2026. Helus Pharma Inc. was founded in 2019 and is headquartered in Toronto, Canada.

Business description based on the company's public filings.

Company information

Legal name
Helus Pharma Inc.
Ticker
NASDAQ: HELP
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Michael I. Halstead J.D.
Employees
100
Headquarters
100 King Street West, Toronto, ON, Canada
Phone
908 764 8385
Website
helus.com
Market cap
$487.68M
SEC CIK
0001833141

Companies similar to Helus Pharma

HELP peer companies
CompanyPrice% ChgMarket capCompare
WVEWave Life Sciences Inc.2.56-5.88%$504.91Mvs HELP
EVOEvotec SE ADR1.32-8.97%$469.11Mvs HELP
MNPRMonopar Therapeutics Inc.69.00-1.84%$467.60Mvs HELP
RZLTRezolute Inc.3.92-6.67%$465.58Mvs HELP
ALMSAlumis Inc.3.96-8.54%$514.09Mvs HELP
BLSMBlossomHill Therapeutics Inc.14.51+0.69%$461.20Mvs HELP
GYREGyre Therapeutics Inc.4.21-6.86%$460.79Mvs HELP
NGNENeurogene Inc.22.15-3.40%$458.53Mvs HELP

Related